Literature DB >> 15742578

Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets.

Kevin Outterson1.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15742578

Source DB:  PubMed          Journal:  Yale J Health Policy Law Ethics        ISSN: 1535-3532


× No keyword cloud information.
  11 in total

1.  A proposal for measuring the degree of public health-sensitivity of patent legislation in the context of the WTO TRIPS Agreement.

Authors:  Gabriela Costa Chaves; Maria Auxiliadora Oliveira
Journal:  Bull World Health Organ       Date:  2007-01       Impact factor: 9.408

2.  Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues.

Authors:  Patricia M Danzon
Journal:  Pharmacoeconomics       Date:  2018-12       Impact factor: 4.981

Review 3.  Challenges for nationwide vaccine delivery in African countries.

Authors:  Mario Songane
Journal:  Int J Health Econ Manag       Date:  2017-10-19

4.  The silent epidemic of exclusive university licensing policies on compounds for neglected diseases and beyond.

Authors:  Connie E Chen; C Taylor Gilliland; Jay Purcell; Sandeep P Kishore
Journal:  PLoS Negl Trop Dis       Date:  2010-03-30

5.  Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010-2020.

Authors:  Kevin Outterson; Ebiowei S F Orubu; John Rex; Christine Årdal; Muhammad H Zaman
Journal:  Clin Infect Dis       Date:  2022-04-09       Impact factor: 20.999

6.  TRIPS, the Doha Declaration and increasing access to medicines: policy options for Ghana.

Authors:  J C Cohen; M Gyansa-Lutterodt; K Torpey; L C Esmail; G Kurokawa
Journal:  Global Health       Date:  2005-12-09       Impact factor: 4.185

7.  Improving access to medicines in poor countries: the role of universities.

Authors:  Dave A Chokshi
Journal:  PLoS Med       Date:  2006-04       Impact factor: 11.069

8.  Closing the access gap for health innovations: an open licensing proposal for universities.

Authors:  Samantha Chaifetz; Dave A Chokshi; Rahul Rajkumar; David Scales; Yochai Benkler
Journal:  Global Health       Date:  2007-02-01       Impact factor: 4.185

9.  Enhancing medicine price transparency through price information mechanisms.

Authors:  Michael Hinsch; Miloud Kaddar; Sarah Schmitt
Journal:  Global Health       Date:  2014-05-08       Impact factor: 4.185

Review 10.  Sustainable vaccine development: a vaccine manufacturer's perspective.

Authors:  Rino Rappuoli; Emmanuel Hanon
Journal:  Curr Opin Immunol       Date:  2018-05-08       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.